KA

Kalamazoo Angels

Description

Kalamazoo Angels

Investor Profile

Kalamazoo Angels has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kalamazoo Angels frequently co-invest with?

BELLE Capital
North America, Michigan, United States, Douglas
Co-Investments: 1
WA
North America, Michigan, United States, Detroit
Co-Investments: 1
Michigan Angel Fund
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
Co-Investments: 1
Co-Investments: 1
Biosciences Research and Commercialization Center (BRCC)
North America, Michigan, United States, Kalamazoo
Co-Investments: 1
Grand Angels
North America, Michigan, United States, Holland
Co-Investments: 1
Blue Water Angels
North America, Michigan, United States, Midland
Co-Investments: 1
AA
North America, Michigan, United States, Ann Arbor
Co-Investments: 1

What are some of recent deals done by Kalamazoo Angels?

Ocuphire Pharma

Farmington Hills, Michigan, United States

Ocuphire Pharma, a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

BiopharmaBiotechnologyPharmaceutical
SeedJul 22, 2019
Amount Raised: $5,000,000